- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on DIABETES MELLITUS, NONINSULIN-DEPENDENT, 2 (Disorder) in Finland
Total 481 results
-
Chromaderm, Inc.CompletedDiabetic Neuropathies | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Insulin-DependentCanada, United States, Croatia, Finland, India, Lithuania, Netherlands, United Kingdom
-
Marja-Riitta TaskinenGöteborg UniversityCompletedType 2 Diabetes MellitusFinland
-
Turku University HospitalUniversity of Turku; University of Helsinki; Academy of Finland; European Foundation... and other collaboratorsUnknownType 2 Diabetes Mellitus | Healthy VolunteersFinland
-
Tampere University HospitalTampere UniversityEnrolling by invitation
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusFinland, Netherlands, Sweden
-
Folkhälsan Researech CenterNärpes Health Care Center, Närpes, Finland; Department of Social Services and... and other collaboratorsCompleted
-
University of OuluUniversity of Texas Southwestern Medical Center; Maastricht University; Finnish...Active, not recruitingType 2 DiabetesFinland
-
University of Eastern FinlandUnknown
-
AstraZenecaCompleted
-
Abbott Diabetes CareRecruitingType 2 Diabetes Treated With InsulinFinland
-
VTT Technical Research Centre of FinlandCompletedHypertension | Diabetes Mellitus Type 2Finland
-
AstraZenecaAntaros Medical; Bioventure Hub; 43183 Mölndal; SwedenCompletedType 2 Diabetes MellitusFinland
-
Kirsi PietiläinenTurku University Hospital; University of HelsinkiRecruitingType2 DiabetesFinland
-
Finnish Institute for Health and WelfareAcademy of FinlandCompleted
-
Finnish Institute for Health and WelfareUniversity of Eastern Finland; University of Oulu; Finnish Diabetes AssociationActive, not recruiting
-
University of Eastern FinlandUniversity of Oslo; Karolinska Institutet; University of Copenhagen; University... and other collaboratorsRecruitingPhysical Activity | Type2 Diabetes | Diet Habit | Life Style | EmpowermentFinland
-
AstraZenecaCompletedDiabetes Mellitus, Non-Insulin-DependentUnited States
-
SanofiPopulation Health Research InstituteCompletedDiabetes Mellitus, Non-Insulin-DependentUnited States, France, Brazil, Poland, Romania, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, India, Philippines, Russian Federation, Slovakia, Mexico, Argentina, Croatia, Austria, Denmark, Finland, Hungary, Lithuania, Norw... and more
-
AlizymeCompletedObesity | Non-Insulin-Dependent Diabetes MellitusFinland, Netherlands, Denmark, United Kingdom, Sweden
-
Turku University HospitalSmithKline BeechamCompletedType 2 Diabetes | Insulin SensitivityFinland
-
Folkhälsan Researech CenterLund University; University of Padova; University of Pavia; Medtronic; Universidad... and other collaboratorsCompletedDiabetes Mellitus, Type 2Finland
-
Turku University HospitalLund UniversityCompletedObesity | Type 2 DiabetesFinland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesFinland
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Finland
-
AstraZenecaCompletedDiabetes Mellitus, Non-Insulin-DependentUnited States
-
University of OuluOulu University HospitalCompleted
-
Sigrid Therapeutics ABCompletedOverweight | PreDiabetes | Prediabetic State | Type2 Diabetes | Obese | Type2 Diabetes Mellitus | Pre DiabetesFinland, Sweden
-
Turku University HospitalAntaros MedicalCompletedDiabetes Mellitus, Type 2Finland
-
Helsinki University Central HospitalUnknownDiabetes Mellitus, Type 2 | Anticoagulant DrugsFinland
-
QuiOSHL Medical; MidMichigan HealthUnknown
-
Tampere University HospitalTampere UniversityActive, not recruitingHyperglycemia | Diabetes Mellitus, Type 2 | Hypoglycemia | Cognitive Impairment | MoodFinland
-
Solvay PharmaceuticalsTerminatedType 2 Diabetes | DyslipidemiaFinland, Ireland, Italy
-
AstraZenecaTerminatedType 2 DiabetesItaly, Finland, United Kingdom
-
SanofiCompletedObesity | Diabetes Mellitus, Non-Insulin-Dependent | Obesity in DiabetesUnited States, France, Canada, Poland, Germany, Netherlands, Belgium, Czech Republic, Argentina, Finland, United Kingdom
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Cheryl Rosenfeld, DOAmylin Pharmaceuticals, LLC.UnknownType 2 Diabetes MellitusUnited States
-
Rhode Island HospitalCompletedSmoking | Type 2 DiabetesUnited States
-
AstraZenecaAstra Zeneca, Bristol-Myers SquibbCompletedType 2 Diabetes MellitusUnited States, Netherlands, Canada
-
Northwell HealthCompletedType 2 Diabetes Mellitus | Vitamin B12 DeficiencyUnited States
-
Rhode Island HospitalCompletedType 2 Diabetes | At-risk DrinkingUnited States
-
Turku University HospitalUniversity of Turku; Kuopio University Hospital; University of Eastern FinlandRecruitingCardiovascular Diseases | Obesity | Diabetes Mellitus, Type 2 | Insulin Resistance | PreDiabetes | Lipid Metabolism DisordersFinland
-
AstraZenecaCompletedDiabetes Mellitus Type 2United States, Australia, Canada, Denmark, Finland, Germany, Israel, Italy, Japan, Korea, Republic of, Norway, Portugal, Singapore, Spain, Sweden, Taiwan, United Kingdom
-
University of HelsinkiActive, not recruitingCardiovascular Diseases | Colorectal Cancer | Type2 DiabetesFinland
-
UKK InstituteUniversity of Eastern Finland; North Karelia Hospital DistrictUnknown
-
Valeritas, Inc.Integrated Medical DevelopmentCompletedType 2 Diabetes MellitusUnited States
-
InteKrin Therapeutics, Inc.CompletedType 2 Diabetes MellitusUnited States, Mexico
-
ConjuChemTerminatedType 2 Diabetes Mellitus (T2DM)United States, Canada
-
The Miriam HospitalRhode Island Hospital; University of Massachusetts, LowellCompletedDiabetes Mellitus, Type 2United States